Bluejay Diagnostics

Bluejay Diagnostics Dividend Yield

Dividend Yield of Bluejay Diagnostics (BJDX) as of Oct 17, 2026.

Dividend Yield

-

Last updated:

Dividend Yield of Bluejay Diagnostics is 2026 - . Dividend Yield of Bluejay Diagnostics was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bluejay Diagnostics Stock analysis

What does Bluejay Diagnostics do? Bluejay Diagnostics Inc operates in the Health Care sector with headquarters in Acton, Massachusetts. The company has 16 employees and went public on November 10, 2021. Its Symphony System is a near-patient testing platform for disease triage and monitoring, measuring key diagnostic biomarkers in whole blood. The Symphony analyzer processes blood non-thermally, isolates biomarkers, and prepares immunoassays. The company's first product, an IL-6 test for sepsis triage, delivers results in about 20 minutes from sample to result. Bluejay Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bluejay Diagnostics stock

On Eulerpool you can find the complete historical development of Dividend Yield Bluejay Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's Bluejay Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Bluejay Diagnostics

All Key Metrics — Bluejay Diagnostics